Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.
| Current Price | ₹272.05 |
|---|---|
| Market Cap | ₹346 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | 48.7 |
| Return on Equity | 3.12% |
| 52-Week Range | ₹216.95 – ₹447.65 |
| Beta (1Y) | 0.76 |
| Dividend Yield | 0.37% |
1. Pharmaceuticals Formulations-100%
Medicamen Biotech Ltd is trading at ₹272.05, with a market capitalisation of ₹346 Cr.
Medicamen Biotech Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Medicamen Biotech Ltd has a P/E of 48.7 and a return on equity of 3.12%.